We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

U.S., European Courts Deal Another Blow to AstraZeneca's Ulcer Drug

Law360 (December 11, 2003, 12:00 AM EST) -- Courts in Europe and the U.S. dealt further setbacks for AstraZeneca’s efforts to extend patent rights to an ulcer treatment that was once the world’s best-selling drug.

A three-judge panel of the United States Court of Appeals upheld the right of SchwarzPharma AG to sell cheaper versions of Prilosec (known as Losec in Europe), but upheld AstraZeneca's patents and affirmed that Andrx, Genpharm and Cheminor infringed them.

Meanwhile, the Luxembourg-based European Court of Justice ruled against the European drug maker’s bid to extend a European patent...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.